Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
93,104,451
-
Number of holders
-
178
-
Total 13F shares, excl. options
-
72,340,160
-
Shares change
-
-4,376,537
-
Total reported value, excl. options
-
$1,035,278,531
-
Value change
-
-$106,690,504
-
Put/Call ratio
-
224%
-
Number of buys
-
80
-
Number of sells
-
99
-
Price
-
$14.31
Institutional Holders of MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) as of Q1 2020
As of 31 Mar 2020 MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) had 256 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 72,340,160 shares of stock of the company.
Largest 10 holders included BlackRock Inc., BAILLIE GIFFORD & CO, VANGUARD GROUP INC, EARNEST PARTNERS LLC, STATE STREET CORP, DISCIPLINED GROWTH INVESTORS INC /MN, DIMENSIONAL FUND ADVISORS LP, D. E. Shaw & Co., Inc., Camber Capital Management LP, and NORTHERN TRUST CORP.
This table shows 256 institutional shareholders of the security as of 31 Mar 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.